Exact Mass: 660.1931
Exact Mass Matches: 660.1931
Found 119 metabolites which its exact mass value is equals to given mass value 660.1931
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2)-rhamnoside
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
(1S,3R,4S,5R)-4-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-3,5-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
3,4-Di-O-caffeoyl-5-O-(3-hydroxy-3-methyl) glutaroyl quinic acid|3,4-dicaffeoyl-5-(3-hydroxy-3-methylglutaroyl)quinic acid
3,4-methylenedioxy-4-methoxy-5-alpha-L-arabinopyranosyloxy-7-beta-D-glucopyranosyloxy-2,7-cycloligna-7,7-dien-9,9-olide|reticulatuside A
4-[6-O-(5-O-(dimethoxycinnamic acid)-beta-apiofuranosyl)-beta-glucopyranoside]-5-methylcoumarin
3-O--catechin-<5,6-e>-4beta-(3,4-dihydroxyphenyl)-dihydro-2(3H)-pyranone
2-O-RHAMNOSYLICARISIDE II
2''-O-Rhamnosylicariside II is a flavonoid glycoside compound and might be beneficial for improving postmenopausal osteoporosis.
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
(3R,5R)-4-(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid
(3R,5R)-4-(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid [IIN-based: Match]
(3R,5R)-4-(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid [IIN-based on: CCMSLIB00000848162]
(1S,3R,4S,5R)-4-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-3,5-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid_4.5\\%
(1S,3R,4S,5R)-4-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-3,5-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid_minor
(1S,3R,4S,5R)-4-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-3,5-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid_major
PEONIN CHLORIDE(SH)
Peonidin 3,5-diglucoside is a member of the class of compounds known as anthocyanidin-5-o-glycosides. Anthocyanidin-5-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C5-position. Peonidin 3,5-diglucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3,5-diglucoside can be found in chives, common grape, pineapple, and sea-buckthornberry, which makes peonidin 3,5-diglucoside a potential biomarker for the consumption of these food products.
(-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(L)TETRAFLUOROBORATE
Hexafluronium Bromide
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
(11bR)-2,6-Bis([1,1-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
4-O-(4-Carboxy-3-hydroxy-3-methylbutanoyl)-3,5-di-O-caffeoylquinic acid
5-hydroxy-7-(4-hydroxyphenyl)-2-methyl-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]pyrano[3,2-g]chromen-6-one
Elloramycin A
A member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogens at position 8 and 10 a are replaced by a 2,3,4-tri-O-methyl-alpha-L-rhamnosyl and methyl groups respectively.
6,12-bis(3,4-dihydroxyphenyl)-8-hydroxy-4-oxo-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-13-yl 5-(3,4-dihydroxyphenyl)-3-hydroxypentanoate
(2e)-8-[(3r,4s,5r)-3-(acetyloxy)-5-{[(2e)-8-[(1s,5r,6s)-5-(acetyloxy)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2-methyl-6-methylideneoct-2-en-7-ynoyl]oxy}-4-hydroxy-6-oxocyclohex-1-en-1-yl]-2-methyl-6-methylideneoct-2-en-7-ynoic acid
n-{4-[(3s)-19-{[(2s,4s,5r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-9-methyl-4,14,21-trioxo-5-oxa-2-azapentacyclo[11.8.0.0²,⁶.0⁷,¹².0¹⁵,²⁰]henicosa-1(13),7,9,11,15,17,19-heptaen-3-yl]butyl}-2,2,2-trifluoroethanimidic acid
18-(acetyloxy)-20-(furan-3-yl)-2,3,4-trihydroxy-5,14,19-trimethyl-8,22-dioxo-9,13,15,21,25-pentaoxaoctacyclo[12.10.1.1⁵,¹².0¹,¹⁶.0³,¹².0⁶,¹¹.0¹¹,¹⁶.0¹⁹,²⁴]hexacosan-17-yl acetate
(2s,3r,4s,5s,6r)-2-(4-{4-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy}-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
4-{[(1s,2r,4s,6r)-2,6-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-4-(methoxycarbonyl)cyclohexyl]oxy}-3-hydroxy-3-methyl-4-oxobutanoic acid
4-{2-hydroxy-4-[2-methoxy-3,5,6-trimethyl-4-(sulfooxy)benzoyloxy]-3,5,6-trimethylbenzoyloxy}-2-methoxy-3,5,6-trimethylbenzoic acid
6-{[(2r)-6,11-dihydroxy-2,5-dimethyl-10-oxo-1-oxa-5-azatetraphen-2-yl]methoxy}-7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one
2''-o-rhamnosyl icariside ii
{"Ingredient_id": "HBIN006265","Ingredient_name": "2''-o-rhamnosyl icariside ii","Alias": "NA","Ingredient_formula": "C33H40O14","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=C(C(=CC(=C4C3=O)O)O)CC=C(C)C)C5=CC=C(C=C5)OC)C)O)O)O)O)O","Ingredient_weight": "660.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18726","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "123134743","DrugBank_id": "NA"}
3,4-di-o-caffeoyl-5-o-(3-hydroxy-3-methyl)glutaroyl quinicacid
{"Ingredient_id": "HBIN007459","Ingredient_name": "3,4-di-o-caffeoyl-5-o-(3-hydroxy-3-methyl)glutaroyl quinicacid","Alias": "NA","Ingredient_formula": "C31H32O16","Ingredient_Smile": "CC(CC(=O)O)(CC(=O)OC1CC(CC(C1OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)(C(=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15026","TCMID_id": "5410","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,5-di-o-caffeoyl-4-o-(3-hydroxy-3-methyl)glutaroylquinicacid
{"Ingredient_id": "HBIN007671","Ingredient_name": "3,5-di-o-caffeoyl-4-o-(3-hydroxy-3-methyl)glutaroylquinicacid","Alias": "3,5-di-o-caffeoyl-4-o-(3-hydroxy-3-methyl)glutaroylquinic acid; (5R)-4-(3,5-dihydroxy-3-methyl-5-oxopentanoyl)oxy-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1-hydroxycyclohexane-1-carboxylic acid; AC1NSUGU","Ingredient_formula": "C31H32O16","Ingredient_Smile": "CC(CC(=O)O)(CC(=O)OC1C(CC(CC1OC(=O)C=CC2=CC(=C(C=C2)O)O)(C(=O)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15027;SMIT19166","TCMID_id": "30902;5411","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anhydroicaritin-3-o-alpha-l-rhamnopyranosyl-(1-2)-alpha-l-rhamnopyranoside
{"Ingredient_id": "HBIN016164","Ingredient_name": "anhydroicaritin-3-o-alpha-l-rhamnopyranosyl-(1-2)-alpha-l-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C33H40O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anhydroicaritin-3-o-α-l-rhamnopyranosyl-(1→2)-α-l-rhamnopyranoside
{"Ingredient_id": "HBIN016165","Ingredient_name": "anhydroicaritin-3-o-\u03b1-l-rhamnopyranosyl-(1\u21922)-\u03b1-l-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C33H40O14","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O)O)C5=CC=C(C=C5)OC)C)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1274","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}